首页> 外文期刊>Bone marrow transplantation >The challenge of COVID-19 and hematopoietic cell transplantation: EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy (vol 47, pg 121, 2020)

【24h】

The challenge of COVID-19 and hematopoietic cell transplantation: EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy (vol 47, pg 121, 2020)

机译：Covid-19和造血细胞移植的挑战：EBMT造血细胞移植受者，捐赠者和患者进行汽车T细胞疗法的建议（Vol 47，PG 121,2020）

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Bone marrow transplantation》 |2021年第3期|共1页
作者
Ljungman Per; Mikulska Malgorzata; de la Camara Rafael; Basak Grzegorz W.; Chabannon Christian; Corbacioglu Selim; Duarte Rafael; Dolstra Harry; Lankester Arjan C.; Mohty Mohamad; Montoto Silvia; Murray John; de Latour Regis Peffault; Snowden John A.; Yakoub-Agha Ibrahim; Verhoeven Bregje; Kroeger Nicolaus; Styczynski Jan;
展开▼
作者单位

Fdn Hematon Utrecht Netherlands;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类治疗学;
关键词

相似文献

外文文献
中文文献
专利

1. Infusions of recipient-derived cytokine-induced killer cells of donor origin eradicated residual disease in a relapsed leukemia patient after allo-hematopoietic stem cell transplantation [J] . ZHONG Zhao-dong, LUO Yi, ZOU Ping, 中华医学杂志（英文版） . 2012,第009期
2. Donor-Derived CD19-Targeted T Cell Infusion Eliminates B Cell Acute Lymphoblastic Leukemia Minimal Residual Disease with No Response to Donor Lymphocytes after Allogeneic Hematopoietic Stem Cell Transplantation [J] . Yifei Cheng, Kaiyan Liu, Shasha Wang, 工程（英文） . 2019,第001期
3. Donor-Derived CD19-Targeted T Cell Infusion Eliminates B Cell Acute Lymphoblastic Leukemia Minimal Residual Disease with No Response to Donor Lymphocytes after Allogeneic Hematopoietic Stem Cell Transplantation [J] . Yifei Cheng, Yuhong Chen, Chenhua Yan, 工程（英文） . 2019,第001期
4. Current status and development of hematopoietic stem cell transplantation in China： a report from Chinese Hematopoietic Stem Cell Transplantation Register Group [J] . XU Lan-ping, HUANG Xiao-jun 中华医学杂志：英文版 . 2011,第016期
5. The challenge of COVID-19 and hematopoietic cell transplantation; EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy [J] . Ljungman Per, Mikulska Malgorzata, de la Camara Rafael, Bone marrow transplantation . 2020,第11期

机译：Covid-19和造血细胞移植的挑战; EBMT用于管理造血细胞移植受者，捐赠者和患者进行汽车T细胞疗法的建议
6. Management of adults and children undergoing chimeric antigen receptor T-cell therapy: best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) [J] . Ibrahim Yakoub-Agha, Christian Chabannon, Peter Bader, Haematologica . 2020,第2期

机译：经过嵌合抗原受体T细胞治疗的成人和儿童管理：欧洲血液和骨髓移植（EBMT）和ISCT和EBMT联合认证委员会的最佳实践建议（Jacie）
7. The European Society for Blood and Marrow Transplantation (EBMT) consensus recommendations for donor selection in haploidentical hematopoietic cell transplantation [J] . Ciurea Stefan O., Al Malki Monzr M., Kongtim Piyanuch, Bone marrow transplantation . 2020,第1期

机译：欧洲血液和骨髓移植学会（EBMT）寄生造血细胞移植中供体选择的共识建议
8. Extraorally delivered photobiomodulation therapy for prevention of oropharyngeal mucositis in pediatric patients undergoing hematopoietic cell transplantation [C] . Christine N. Duncan, Anna N. Yaroslavsky, Wendy B. London, Mechanisms of photobiomodulation therapy XII . 2017

机译：外用光生物调节疗法预防小儿造血细胞移植患者的口咽粘膜炎
9. Donor selection for patients undergoing allogeneic hematopoietic stem cell transplantation: Assessment of the priorities of Canadian hematopoietic stem cell transplant physicians. [D] . Tay, Jason. 2009

机译：接受同种异体造血干细胞移植的患者的供体选择：加拿大造血干细胞移植医生的优先事项评估。
10. Management of adults and children undergoing chimeric antigen receptor T-cell therapy: best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) [O] . Ibrahim Yakoub-Agha, Christian Chabannon, Peter Bader, 2020

机译：接受嵌合抗原受体T细胞治疗的成人和儿童的管理：欧洲血液和骨髓移植学会（EBMT）以及ISCT和EBMT联合鉴定委员会（JACIE）的最佳实践建议
11. Management of adults and children undergoing chimeric antigen receptor T-cell therapy: best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) [O] . Ibrahim Yakoub-Agha, Christian Chabannon, Peter Bader, 2019

机译：经过嵌合抗原受体T细胞治疗的成人和儿童管理：欧洲血液和骨髓移植（EBMT）和ISCT和EBMT联合认证委员会的最佳实践建议（Jacie）
12. Development of Augmented Leukemia/Lymphoma-Specific T-Cell Immunotherapy for Deployment with Haploidentical Hematopoietic Progenitor-Cell Transplant. [R] . Cooper, L. 2010

机译：发展增强白血病/淋巴瘤特异性T细胞免疫治疗部署与单倍体相合的造血祖细胞移植。

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号